+91 9425150513 (Asia)        

  
LED BY INTEGRITY, FUELED BY DATA BUILT ON SCIENCE,
POWERED BY PASSION Founded in 2017, 24LifeSciences is a dedicated healthcare research and consulting partner serving pharmaceutical, biotechnology, medical device, diagnostics, and digital health companies worldwide. We help clients understand evolving markets, anticipate trends, benchmark performance, and identify new growth opportunities through evidence-based insights. Our multi-disciplinary team of industry analysts, life science experts, data modelers, and domain consultants ensures that every report and advisory project we deliver stands on the foundation of scientific accuracy, commercial viability, and actionable relevance
Why Choose 24LifeSciences?
01.
Market Sizing & Forecasting
01.
Market Sizing & Forecasting

We deliver precise market models for 5, 10, and 15-year outlooks using robust data sources and scenario analysis. Our forecasting takes into account clinical trial outcomes, regulatory pathways, pricing changes, technology diffusion, and competitor activity — offering you both optimistic and conservative projections . Product adoption & demand Pipeline maturity curves Reimbursement evolution Addressable & serviceable markets

02.
Product Pipeline & Innovation Mapping
02.
Product Pipeline & Innovation Mapping

We map out product development pipelines across drug classes, delivery platforms, and therapeutic categories. Our innovation tracking highlights: Emerging modalities (mRNA, cell therapy, CRISPR, ADCs) First-in-class or best-in-class products in the pipeline Key milestones, partnerships, and licensing trends Early-stage assets with high disruption potential

03.
Competitive Intelligence & Benchmarking
03.
Competitive Intelligence & Benchmarking

Stay ahead of your competitors with our deep-dive CI reports that analyze: Key player strategies SWOT analysis Clinical trial outcomes and regulatory filings Commercialization models Portfolio positioning and innovation lifecycle

04.
Technology & Regulatory Landscape Reports
04.
Technology & Regulatory Landscape Reports

We continuously monitor advancements in medical devices, diagnostic tools, drug delivery systems, and regulatory changes (FDA, EMA, CDSCO, etc.) to deliver: Regulatory timelines and risk assessments Market access and reimbursement updates Disruptive tech trends across medtech, biotech, and eHealth

05.
Therapeutic Area Studies
05.
Therapeutic Area Studies

Our team specializes in disease-specific insights across high-growth and underserved areas, including: Oncology – Solid tumors, hematologic malignancies, immunotherapies Immunology – Autoimmune conditions, monoclonal antibodies, biosimilars Rare Diseases – Market access, orphan drug incentives, patient advocacy impact Neurology – Alzheimer’s, Parkinson’s, epilepsy, neurodevelopmental disorders Cardiovascular – Heart failure, stroke, cholesterol management, interventions

Empowering Decisions with Data

Use Cases for Our Reports

Our research reports aren’t just data repositories — they’re actionable tools that support mission-critical functions across departments:

  • Business performance
  • Predict behavior
  • Drive strategic
  • Business performance
  • Understand customers
  • Predict behavior
  • Identify trends
  • insights into data
Our Foundation of Excellence

Empowering Innovation and Integrity Across Every Endeavor!

01

OUR VISION

To become the most trusted global intelligence partner for the healthcare and life sciences ecosystem, enabling evidence-based growth, innovation, and patient impact.

02

OUR MISSION

To transform complex healthcare data into actionable insights that drive better strategic, scientific, and commercial outcomes.

03

OUR VALUES

Integrity: We ensure accuracy and transparency in every insight.

Innovation: We evolve with advancing science.

Impact: Our reports drive real-world change.

Customer

Discover Customer Successful Stories

image
image
image
image
image
image
image
image
image
main-image
image